Javaid Asad, Poongkunran Mugilan, Allard Felicia D, Kyaw Win, Maung Htet Htet, Lau Daryl
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA and.
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Gastroenterol Rep (Oxf). 2017 May;5(2):157-160. doi: 10.1093/gastro/gov064. Epub 2016 Feb 17.
We are describing an interesting case of two chronic liver diseases in a 48-year-old Chinese woman. While chronic hepatitis B is a common entity in Asia, the patient was later found to have active, asymptomatic primary biliary cirrhosis due to a persistently elevated alkaline phosphatase level after optimal hepatitis B virus DNA suppression on antiviral therapy. This report emphasizes the importance of keeping a high index of suspicion for another potential liver disease process even after a patient has been successfully treated for a primary liver condition. Clinical vigilance, especially in atypical clinical presentations, can result in early accurate diagnosis and prompt treatment.
我们正在描述一名48岁中国女性患两种慢性肝病的有趣病例。虽然慢性乙型肝炎在亚洲是一种常见疾病,但在对抗病毒治疗进行优化后,患者乙肝病毒DNA得到有效抑制,但碱性磷酸酶水平持续升高,后来被发现患有活动性、无症状原发性胆汁性肝硬化。本报告强调,即使患者已成功治疗原发性肝脏疾病,仍需高度怀疑是否存在其他潜在肝病进程。临床警惕性,尤其是在非典型临床表现中,可实现早期准确诊断和及时治疗。